It may have been covered on the YMB, but I don't agree with the analysis. I think they only had cash through about Sep/Oct. So unless they got a license immediately from the interim results, they'd be scraping the barrel again and the partner could play hardball.
Now they have cash on hand for an extra 3-5 months. Less need, more options. Also, if they don't enroll/hit 190 PFS for another 3-5 weeks, I could see the SP slump under $3 again. They get cash in hand with this deal.
>>What could be the reasons that they would suddenly need more cash? Good or bad
They said in the PR the proceeds could go "for general corporate purposes, including the funding of the clinical development of its product pipeline of cancer drugs."
I believe they are using this to get the liver mets trial going the absolute second that HEAT finishes enrolling. Possibly the RCW ph2 trial also.
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM